BIVIS President Mr. Joe Chan and Foundation Director Mr. Lewis Pond, as well as BIVIS Project Manager Mr. Hank Shi, were invited to attend the ceremony. And, it is an honor to meet with Dr. Chao Chung-Chieh, Chairman of Taipei Medical Alliance, also Mr. Yen Wang, President of TCT, and Dr. Chiu Lin-Bin, a leader in the CIVIC engineering, and Mr. Keo Hour, GM of U.C. Pharma. During the public meeting, we had ideals exchange with the officials on the ESG topics of future pharmaceutical and medical institutions.

It is a special honor to deepen our cooperation intention with Mr. Victor Wang, Senior Vice General Manager of CDIB Capital, to jointly invest in and establish Taiwan’s grid level BESS with future collaboration . This has added a huge boost to BIVIS’s entry into the Taiwan ESS market.

The partners of this MOU come from elites in the medical industry, government and academia. d Lukasz Piotr Lanski, chief representative of the Polish Investment and Trade Taipei Office, was specially invited to participate in the grand event. Dr. Chao Chung-Chieh, Chairman of theTaipei Medical Alliance, said that this cooperation will not only promote innovation in medical technology, but also further expand the accessibility of medical services and provide better health care to the public. Taipei Medical Alliance and its partners emphasized their common mission, which is to combine medical resources and industrial innovation to jointly address various challenges faced by the current medical system. Through resource sharing, experience exchange and technical cooperation, we hope to inject new momentum into Taiwan’s medical development.

At the signing ceremony, Mr. Lu Jiande, Honorary Chairman of the Taipei Medical Alliance and Vice Ministry of Health and Welfare, emphasized that the improvement of medical services requires not only medical expertise, but also hopes to integrate everyone’s strength and support from multiple aspects to jointly promote medical reform and jointly solve the current medical problems. system challenges and promote innovative medical solutions.

In the future, the Taipei Medical Alliance will continue to work closely with industry partners to promote various public welfare projects and regularly review the effectiveness of cooperation to ensure the achievement of various goals. The signing of this MOU marks the beginning of a new cooperation. In the future, both parties will work together to improve the overall level of Taiwan’s medical health and bring greater benefits to society.